Bull
$96.26
Scenario price
$69.280
-1.240 (-1.79%)At close
Cognizant Technology Solutions Corporation engineers modern businesses. Its services include artificial intelligence (AI) and other technology services and solutions, consulting, application development, systems integration, quality engineering and assurance, application maintenance, infrastructure and security as well as business process services and automation. Its segments include Health Sciences (HS), Financial Services (FS), Products and Resources (P&R), and Communications, Media and Technology (CMT). HS segment consists of healthcare providers and payers, and life sciences companies. FS segment includes banking, capital markets, payments and insurance companies. P&R segment includes manufacturers, automakers, retailers, consumer goods companies, and travel and hospitality companies, as well as businesses providing logistics, energy and utility services. CMT segment includes global communications, media and entertainment, education, information services and technology companies.
Cognizant Technology Solutions Corp is a good buy right now, trading at $70.54 with a forward P/E of 9.41, indicating it is undervalued compared to its earnings potential. The recent acquisition of DyFlex Solutions is expected to enhance its AI capabilities, which is a positive catalyst. However, the stock has a recent 5-day change of +6.83%, suggesting some upward momentum, but it also faces risks from broader market declines, as evidenced by the S&P 500's recent performance of -0.52%.
Deutsche Bank
$70
2026-09-18
Deutsche Bank
2026-09-18
Price Target
$70
JPMorgan
$67
2026-07-30
JPMorgan
2026-07-30
Price Target
$67
Susquehanna
$82
2026-07-30
Susquehanna
2026-07-30
Price Target
$82
Morgan Stanley
$51
2026-07-30
Morgan Stanley
2026-07-30
Price Target
$51
Citi
$60
2026-07-30
Citi
2026-07-30
Price Target
$60
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Cognizant Partners with EBRD for Five-Year Tech Transformation

Cognizant Partners with EBRD to Accelerate Digital Transformation

Major Risks Loom for Stock Market Next Week Amid AI Trade Stumbles

Cognizant Launches AI Nexus to Accelerate Enterprise Value from AI Investments

Cognizant Acquires DyFlex to Enhance AI and SAP Capabilities
Cognizant Technology Solutions Corporation engineers modern businesses. Its services include artificial intelligence (AI) and other technology services and solutions, consulting, application development, systems integration, quality engineering and assurance, application maintenance, infrastructure and security as well as business process services and automation. Its segments include Health Sciences (HS), Financial Services (FS), Products and Resources (P&R), and Communications, Media and Technology (CMT). HS segment consists of healthcare providers and payers, and life sciences companies. FS segment includes banking, capital markets, payments and insurance companies. P&R segment includes manufacturers, automakers, retailers, consumer goods companies, and travel and hospitality companies, as well as businesses providing logistics, energy and utility services. CMT segment includes global communications, media and entertainment, education, information services and technology companies. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING SERVICES industry).
Cognizant Technology Solutions Corp is a good buy right now, trading at $70.54 with a forward P/E of 9.41, indicating it is undervalued compared to its earnings potential. The recent acquisition of DyFlex Solutions is expected to enhance its AI capabilities, which is a positive catalyst. However, the stock has a recent 5-day change of +6.83%, suggesting some upward momentum, but it also faces risks from broader market declines, as evidenced by the S&P 500's recent performance of -0.52%.
33 analysts cover CTSH: 24 rate it Buy, 9 Hold and 0 Sell. The average price target is 87.18.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.